(19)
(11) EP 0 796 259 A2

(12)

(43) Date of publication:
24.09.1997 Bulletin 1997/39

(21) Application number: 95941073.0

(22) Date of filing: 06.12.1995
(51) International Patent Classification (IPC): 
C07D 317/ 16( . )
C07C 69/ 78( . )
C07D 317/ 22( . )
C07D 317/ 28( . )
C07D 495/ 04( . )
 A01N 43/ 54( . )
C07D 317/ 20( . )
C07D 317/ 24( . )
C07D 405/ 12( . )
(86) International application number:
PCT/EP1995/004795
(87) International publication number:
WO 1996/017843 (13.06.1996 Gazette 1996/27)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

(30) Priority: 07.12.1994 GB 19940024676

(71) Applicants:
  • Novartis AG
    4058 Basel (CH)
  • SANDOZ-PATENT-GMBH
    79539 Lörrach (DE)
  • Novartis-Erfindungen Verwaltungsgesellschaft m.b.H.
    1230 Wien (AT)

(72) Inventors:
  • LAMBERTH, Clemens
    D-79595 Ruemmingen (DE)
  • SCHAUB, Fritz
    CH-4147 Aesch (CH)

   


(54) NOVEL PYRIMIDINYLOXY- AND PYRIMIDINYLAMINO-ETHYLPHENYL-DIOXOLANE DERIVATIVES